AZD-9291 (Osimertinib)
AZD-9291 是一种第三代 EGFR 抑制剂,在临床前研究中显示出潜力,并为那些对现有 EGFR 抑制剂 产生耐药性的晚期肺癌患者提供了希望。
全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
重要通知:仅供研究使用。我们不向患者销售。
Discription | AZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A13681 |
---|---|
分子式 | C28H33N7O2 |
分子量 | 499.61 |
CAS号 | 1421373-65-0 |
SMILES | CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC |
其他名称 | AZD 9291, AZD9291 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Warmed: 90 mg/mL (180.14 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 39 mg/mL (78.05 mM) | ||
In vivo | 5%DMSO+40%PEG300+5%Tween80+50%ddH2O | 7.1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.02 mL | 100.08 mL | 200.16 mL |
0.5 mM | 4 mL | 20.02 mL | 40.03 mL |
1 mM | 2 mL | 10.01 mL | 20.02 mL |
5 mM | 0.4 mL | 2 mL | 4 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2